Biocompatibility assessment of Si-based nano- and micro-particles

Advanced Drug Delivery Reviews

Volumn 64, Issue 15, 2012, Pages 1800-1819

  Jaganathan, Hamsa ^a   Godin, Biana ^a  

^a HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

Biocompatibility; Mesoporous; Nanomaterials; Silica; Silicon; Toxicity

Indexed keywords

BUILDING AND CONSTRUCTION; FOOD INDUSTRIES; GENOTOXIC EFFECTS; MESOPOROUS; MICRO-PARTICLES; SI-BASED; SILICON-BASED MATERIALS;

BIOCOMPATIBILITY; CHEMICAL ELEMENTS; CONSUMER PRODUCTS; NANOSTRUCTURED MATERIALS; SILICA; SILICON; TOXICITY;

NANOPARTICLES;

CARBON; NANOPARTICLE; SILICON; SILICON DIOXIDE;

BIOCOMPATIBILITY; CELL VIABILITY; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CONCENTRATION (PARAMETERS); ENDOTHELIUM CELL; EPITHELIUM CELL; ERYTHROCYTE; FIBROBLAST; GENOTOXICITY; HUMAN; HYDROGEN BOND; IN VITRO STUDY; MACROPHAGE; MEMBRANE MICROPARTICLE; MOLECULAR DYNAMICS; NANOANALYSIS; NANOFABRICATION; NONHUMAN; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SURFACE PROPERTY;

ANIMALS; BIOCOMPATIBLE MATERIALS; HUMANS; MICROSPHERES; MUTAGENS; NANOPARTICLES; PARTICLE SIZE; SILICON; SILICON DIOXIDE;

EID: 84869155482     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.05.008     Document Type: Review

References (212)

1. Ma J.F. Plant root responses to three abundant soil minerals: silicon, aluminum and iron. Crit. Rev. Plant Sci. 2005, 24:267-281.
2. Morse D.E. Silicon biotechnology: harnessing biological silica production to construct new materials. Trends Biotechnol. 1999, 17:230-232.
3. Kenneth K.O., Kim K., Floyd B.A., Mehta J.L., Yoon H., Hung C.M., Bravo D., Dickson T.O., Guo X.L., Li R., Trichy N., Caserta J., Bomstad W.R., Branch J., Yang D.J., Bohorquez J., Seok E., Gao L., Sugavanam A., Lin J.J., Chen J., Brewer J.E. On-chip antennas in silicon ICs and their application. IEEE Trans. Electron Devices 2005, 52:1312-1323.
4. Van Dyck K., Van Cauwenbergh R., Robberecht H., Deelstra H. Bioavailability of silicon from food and food supplements. Fresenius J. Anal. Chem. 1999, 363:541-544.
5. Braley S. The chemistry and properties of the medical-grade silicones. J. Macromol. Sci. Chem. 1970, 4:529-544.
6. Luhrs A.K., Geurtsen W. The application of silicon and silicates in dentistry: a review. Prog. Mol. Subcell. Biol. 2009, 47:359-380.
7. Lewinski N., Colvin V., Drezek R. Cytotoxicity of nanoparticles. Small 2008, 4:26-49.
8. Barbé C., Bartlett J., Kong L., Finnie K., Lin H.Q., Larkin M., Calleja S., Bush A., Calleja G. Silica particles: a novel drug-delivery system. Adv. Mater. 2004, 16:1959-1966.
9. Auffan M., Rose J., Bottero J.-Y., Lowry G.V., Jolivet J.-P., Wiesner M.R. Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective. Nat. Nanotechnol. 2009, 4:634-641.
10. Gill I., Ballesteros A. Encapsulation of biologicals within silicate, siloxane, and hybrid sol-gel polymers: an efficient and generic approach. J. Am. Chem. Soc. 1998, 120:8587-8598.
11. Kong B., Seog J.H., Graham L.M., Lee S.B. Experimental considerations on the cytotoxicity of nanoparticles. Nanomedicine 2011, 6:929-941.
12. Barnard A.S. Nanohazards: knowledge is our first defence. Nat. Mater. 2006, 5:245-248.
13. Li Y., Sun L., Jin M., Du Z., Liu X., Guo C., Li Y., Huang P., Sun Z. Size-dependent cytotoxicity of amorphous silica nanoparticles in human hepatoma HepG2 cells. Toxicol. Vitr. 2011, 25:1343-1352.
14. Huang X., Li L., Liu T., Hao N., Liu H., Chen D., Tang F. The shape effect of mesoporous silica nanoparticles on biodistribution, clearance, and biocompatibility in vivo. ACS Nano 2011, 5:5390-5399.
15. Chung T.-H., Wu S.-H., Yao M., Lu C.-W., Lin Y.-S., Hung Y., Mou C.-Y., Chen Y.-C., Huang D.-M. The effect of surface charge on the uptake and biological function of mesoporous silica nanoparticles in 3T3-L1 cells and human mesenchymal stem cells. Biomaterials 2007, 28:2959-2966.
16. Stern S.T., McNeil S.E. Nanotechnology safety concerns revisited. Toxicol. Sci. 2008, 101:4-21.
17. Bruno G., Capezzuto P., Madan A. Plasma Deposition of Amorphous Silicon-Based Materials 1995, Elsevier Science.
18. Sun L., Gong K. Silicon-based materials from rice husks and their applications. Ind. Eng. Chem. Res. 2001, 40:5861-5877.
19. Nalwa H.S. Silicon-based Materials and Devices 2001, Academic Press.
20. Matsumoto N. Overview of silicon-based materials. Jpn. J. Appl. Phys. Part 1 1998, 37:5425-5436.
21. Lam C.W., James J.T., McCluskey R., Hunter R.L. Pulmonary toxicity of single-wall carbon nanotubes in mice 7 and 90days after intratracheal instillation. Toxicol. Sci. 2004, 77:126-134.
22. Warheit D.B., Laurence B.R., Reed K.L., Roach D.H., Reynolds G.A.M., Webb T.R. Comparative pulmonary toxicity assessment of single-wall carbon nanotubes in rats. Toxicol. Sci. 2004, 77:117-125.
23. Muller J., Huaux F., Moreau N., Misson P., Heilier J.F., Delos M., Arras M., Fonseca A., Nagy J.B., Lison D. Respiratory toxicity of multi-wall carbon nanotubes. Toxicol. Appl. Pharmacol. 2005, 207:221-231.
24. Davoren M., Herzog E., Casey A., Cottineau B., Chambers G., Byrne H.J., Lyng F.M. In vitro toxicity evaluation of single walled carbon nanotubes on human A549 lung cells. Toxicol. Vitr. 2007, 21:438-448.
25. Smith C.J., Shaw B.J., Handy R.D. Toxicity of single walled carbon nanotubes to rainbow trout, (Oncorhynchus mykiss): respiratory toxicity, organ pathologies, and other physiological effects. Aquat. Toxicol. 2007, 82:94-109.
26. Murray A.R., Kisin E., Leonard S.S., Young S.H., Kommineni C., Kagan V.E., Castranova V., Shvedova A.A. Oxidative stress and inflammatory response in dermal toxicity of single-walled carbon nanotubes. Toxicology 2009, 257:161-171.
27. Teo B.K., Sun X.H. Silicon-based low-dimensional nanomaterials and nanodevices. Chem. Rev. 2007, 107:1454-1532.
28. Okamoto H., Sugiyama Y., Nakano H. Synthesis and modification of silicon nanosheets and other silicon nanomaterials. Chem. Eur. J. 2011, 17:9864-9887.
29. Anglin E.J., Schwartz M.P., Ng V.P., Perelman L.A., Sailor M.J. Engineering the chemistry and nanostructure of porous silicon Fabry-Pérot films for loading and release of a steroid. Langmuir 2004, 20:11264-11269.
30. Magarshak Y., Kozyrev S., Vaseashta A. Silicon Versus Carbon: Fundamental Nanoprocesses, Nanobiotechnology and Risks Assessment 2009, Springer, Dordrecht.
31. Erogbogbo F., Yong K.T., Roy I., Xu G., Prasad P.N., Swihart M.T. Biocompatible luminescent silicon quantum dots for imaging of cancer cells. ACS Nano 2008, 2:873-878.
32. van Buuren T., Dinh L.N., Chase L.L., Siekhaus W.J., Terminello L.J. Changes in the electronic properties of si nanocrystals as a function of particle size. Phys. Rev. Lett. 1998, 80:3803-3806.
33. Littau K.A., Szajowski P.J., Muller A.J., Kortan A.R., Brus L.E. A luminescent silicon nanocrystal colloid via a high-temperature aerosol reaction. J. Phys. Chem. 1993, 97:1224-1230.
34. Wilson W.L., Szajowski P.F., Brus L.E. Quantum confinement in size-selected, surface-oxidized silicon nanocrystals. Science 1993, 262:1242-1244.
35. Takagi H., Ogawa H., Yamazaki Y., Ishizaki A., Nakagiri T. Quantum size effects on photoluminescence in ultrafine Si particles. Appl. Phys. Lett. 1990, 56:2379-2380.
36. Ehbrecht M., Kohn B., Huisken F., Laguna M.A., Paillard V. Photoluminescence and resonant Raman spectra of silicon films produced by size-selected cluster beam deposition. Phys. Rev. B 1997, 56:6958-6964.
37. Ledoux G., Gong J., Huisken F., Guillois O., Reynaud C. Photoluminescence of size-separated silicon nanocrystals: confirmation of quantum confinement. Appl. Phys. Lett. 2002, 80:4834-4836.
38. Botti S., Coppola R., Gourbilleau F., Rizk R. Photoluminescence from silicon nano-particles synthesized by laser-induced decomposition of silane. J. Appl. Phys. 2000, 88:3396-3401.
39. Borsella E., Falconieri M., Botti S., Martelli S., Bignoli F., Costa L., Grandi S., Sangaletti L., Allieri B., Depero L. Optical and morphological characterization of Si nanocrystals/silica composites prepared by sol-gel processing. Mater. Sci. Eng. B 2001, 79:55-62.
40. Li X., He Y., Talukdar S.S., Swihart M.T. Process for preparing macroscopic quantities of brightly photoluminescent silicon nanoparticles with emission spanning the visible spectrum. Langmuir 2003, 19:8490-8496.
41. Heath J.R. A liquid-solution-phase synthesis of crystalline silicon. Science 1992, 258:1131-1133.
42. Baldwin R.K., Zou J., Pettigrew K.A., Yeagle G.J., Britt R.D., Kauzlarich S.M. The preparation of a phosphorus doped silicon film from phosphorus containing silicon nanoparticles. Chem. Commun. 2006, 658-660.
43. Baldwin R.K., Pettigrew K.A., Garno J.C., Power P.P., Liu G.-y., Kauzlarich S.M. Room temperature solution synthesis of alkyl-capped tetrahedral shaped silicon nanocrystals. J. Am. Chem. Soc. 2002, 124:1150-1151.
44. Stöber W., Fink A., Bohn E. Controlled growth of monodisperse silica spheres in the micron size range. J. Colloid Interface Sci. 1968, 26:62-69.
45. Ow H., Larson D.R., Srivastava M., Baird B.A., Webb W.W., Wiesner U. Bright and stable core-shell fluorescent silica nanoparticles. Nano Lett. 2004, 5:113-117.
46. Burns A.A., Vider J., Ow H., Herz E., Penate-Medina O., Baumgart M., Larson S.M., Wiesner U., Bradbury M. Fluorescent silica nanoparticles with efficient urinary excretion for nanomedicine. Nano Lett. 2008, 9:442-448.
47. Benezra M., Penate-Medina O., Zanzonico P.B., Schaer D., Ow H., Burns A., DeStanchina E., Longo V., Herz E., Iyer S., Wolchok J., Larson S.M., Wiesner U., Bradbury M.S. Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. J. Clin. Invest. 2011, 121:2768-2780.
48. 2 nanoparticles in a non-ionic reverse micellar system. Colloids Surf. 1990, 50:321-339.
49. Arriagada F.J., Osseo-Asare K. Synthesis of nanosize silica in a nonionic water-in-oil microemulsion: effects of the water/surfactant molar ratio and ammonia concentration. J. Colloid Interface Sci. 1999, 211:210-220.
50. Alexandre M., Dubois P. Polymer-layered silicate nanocomposites: preparation, properties and uses of a new class of materials. Mater. Sci. Eng., R 2000, 28:1-63.
51. Wen L.X., Ding H.M., Wang J.X., Chen J.F. Porous hollow silica nanoparticles as carriers for controlled delivery of ibuprofen to small intestine. J. Nanosci. Nanotechnol. 2006, 6:3139-3144.
52. Chang J.-S., Chang K.L.B., Hwang D.-F., Kong Z.-L. In vitro cytotoxicitiy of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. Environ. Sci. Technol. 2007, 41:2064-2068.
53. Caruso F., Spasova M., Susha A., Giersig M., Caruso R.A. Magnetic nanocomposite particles and hollow spheres constructed by a sequential layering approach. Chem. Mater. 2001, 13:109-116.
54. Correa-Duarte M.A., Giersig M., Kotov N.A., Liz-Marzan L.M. Control of packing order of self-assembled monolayers of magnetite nanoparticles with and without SiO(2) coating by microwave irradiation. Langmuir 1998, 14:6430-6435.
55. Caruso F., Spasova M., Saigueirino-Maceira V., Liz-Marzan L.M. Multilayer assemblies of silica-encapsulated gold nanoparticles on decomposable colloid templates. Adv. Mater. 2001, 13:1090-1094.
56. 2 nanocomposites for metal-enhanced fluorescence and single nanoparticle sensing platforms. J. Am. Chem. Soc. 2007, 129:1524-1525.
57. Selvan S.T., Patra P.K., Ang C.Y., Ying J.Y. Synthesis of silica-coated semiconductor and magnetic quantum dots and their use in the imaging of live cells. Angew. Chem. 2007, 119:2500-2504.
58. Whitsitt E.A., Barron A.R. Silica coated single walled carbon nanotubes. Nano Lett. 2003, 3:775-778.
59. Anglin E.J., Cheng L., Freeman W.R., Sailor M.J. Porous silicon in drug delivery devices and materials. Adv. Drug Deliv. Rev. 2008, 60:1266-1277.
60. Qian K.K., Bogner R.H. Application of mesoporous silicon dioxide and silicate in oral amorphous drug delivery systems. J. Pharm. Sci. 2012, 101:444-463.
61. Slowing I.I., Vivero-Escoto J.L., Wu C.W., Lin V.S. Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers. Adv. Drug Deliv. Rev. 2008, 60:1278-1288.
62. Uhlir A. Electrolytic shaping of germanium and silicon. Bell Syst. Tech. J. 1956, 35:333-347.
63. Canham L.T., Reeves C.L., Loni A., Houlton M.R., Newey J.P., Simons A.J., Cox T.I. Calcium phosphate nucleation on porous silicon: factors influencing kinetics in acellular simulated body fluids. Thin Solid Films 1997, 297:304-307.
64. Jugdaohsingh R., Anderson S.H., Tucker K.L., Elliott H., Kiel D.P., Thompson R.P., Powell J.J. Dietary silicon intake and absorption. Am. J. Clin. Nutr. 2002, 75:887-893.
65. Godin B., Gu J., Serda R.E., Bhavane R., Tasciotti E., Chiappini C., Liu X., Tanaka T., Decuzzi P., Ferrari M. Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation. J. Biomed. Mater. Res. A 2010, 94:1236-1243.
66. Whitehead M.A., Fan D., Mukherjee P., Akkaraju G.R., Canham L.T., Coffer J.L. High-porosity poly(epsilon-caprolactone)/mesoporous silicon scaffolds: calcium phosphate deposition and biological response to bone precursor cells. Tissue Eng. Part A 2008, 14:195-206.
67. Alvarez S.D., Derfus A.M., Schwartz M.P., Bhatia S.N., Sailor M.J. The compatibility of hepatocytes with chemically modified porous silicon with reference to in vitro biosensors. Biomaterials 2009, 30:26-34.
68. Moxon K.A., Hallman S., Aslani A., Kalkhoran N.M., Lelkes P.I. Bioactive properties of nanostructured porous silicon for enhancing electrode to neuron interfaces. J. Biomater. Sci. Polym. Ed. 2007, 18:1263-1281.
69. Hu L., Xu S., Pan C., Zou H., Jiang G. Preparation of a biochip on porous silicon and application for label-free detection of small molecule-protein interactions. Rapid Commun. Mass Spectrom. 2007, 21:1277-1281.
70. Charnay C., Begu S., Tourne-Peteilh C., Nicole L., Lerner D.A., Devoisselle J.M. Inclusion of ibuprofen in mesoporous templated silica: drug loading and release property. Eur. J. Pharm. Biopharm. 2004, 57:533-540.
71. Coffer J.L., Montchamp J.-L., Aimone J.B., Weis R.P. Routes to calcified porous silicon: implications for drug delivery and biosensing. Phys. Status Solidi A 2003, 197:336-339.
72. Vaccari L., Canton D., Zaffaroni N., Villa R., Tormen M., di Fabrizio E. Porous silicon as drug carrier for controlled delivery of doxorubicin anticancer agent. Microelectron. Eng. 2006, 83:1598-1601.
73. Rosenholm J.M., Linden M. Towards establishing structure-activity relationships for mesoporous silica in drug delivery applications. J. Control. Release 2008, 128:157-164.
74. Godin B., Tasciotti E., Liu X., Serda R.E., Ferrari M. Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics. Acc. Chem. Res. 2011, 44:979-989.
75. Fan J., Fang G., Wang X., Zeng F., Xiang Y., Wu S. Targeted anticancer prodrug with mesoporous silica nanoparticles as vehicles. Nanotechnology 2011, 22:455102.
76. Meade S.O., Yoon M.S., Ahn K.H., Sailor M.J. Porous silicon photonic crystals as encoded microcarriers. Adv. Mater. 2004, 16:1811-1814.
77. Park J.H., Gu L., von Maltzahn G., Ruoslahti E., Bhatia S.N., Sailor M.J. Biodegradable luminescent porous silicon nanoparticles for in vivo applications. Nat. Mater. 2009, 8:331-336.
78. Salonen J., Laitinen L., Kaukonen A.M., Tuura J., Bjorkqvist M., Heikkila T., Vaha-Heikkila K., Hirvonen J., Lehto V.P. Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. J. Control. Release 2005, 108:362-374.
79. Chiappini C., Tasciotti E., Fakhoury J.R., Fine D., Pullan L., Wang Y.C., Fu L., Liu X., Ferrari M. Tailored porous silicon microparticles: fabrication and properties. Chemphyschem 2010, 11:1029-1035.
80. Tasciotti E., Liu X., Bhavane R., Plant K., Leonard A.D., Price B.K., Cheng M.M.-C., Decuzzi P., Tour J.M., Robertson F., Ferrari M. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. Nat. Nanotechnol. 2008, 3:151-157.
81. Shen H., Sun T., Ferrari M. Nanovector delivery of siRNA for cancer therapy. Cancer Gene Therapy 2012, 19:367-373.
82. Serda R.E., Godin B., Blanco E., Chiappini C., Ferrari M. Multi-stage delivery nano-particle systems for therapeutic applications. Biochim. Biophys. Acta 2011, 1810:317-329.
83. Godin B., Tasciotti E., Liu X., Serda R.E., Ferrari M. Multistage nanovectors: from concept to novel imaging contrast agents and therapeutics. Acc. Chem. Res. 2011, 44:979-989.
84. van de Ven A.L., Kim P., Haley O., Fakhoury J.R., Adriani G., Schmulen J., Moloney P., Hussain F., Ferrari M., Liu X.W., Yun S.H., Decuzzi P. Rapid tumoritropic accumulation of systemically injected platoid particles and their biodistribution. J. Control Release 2012, 158:148-155.
85. Lee J.E., Lee N., Kim T., Kim J., Hyeon T. Multifunctional mesoporous silica nanocomposite nanoparticles for theranostic applications. Acc. Chem. Res. 2011, 44:893-902.
86. Salonen J., Lehto V.-P. Fabrication and chemical surface modification of mesoporous silicon for biomedical applications. Chem. Eng. J. 2008, 137:162-172.
87. Halimaoui A., Oules C., Bomchil G., Bsiesy A., Gaspard F., Herino R., Ligeon M., Muller F. Electroluminescence in the visible range during anodic oxidation of porous silicon films. Appl. Phys. Lett. 1991, 59:304-306.
88. Zhang L.Z., Zong B.Q., Zhang B.R., Xu Z.H., Li J.Q., Qin G.G. Photoluminescence peak energy evolution for porous silicon during photo-oxidation and gamma-ray oxidation. J. Phys. Condens. Matter 1995, 7:697.
89. Li K.-H., Tsai C., Campbell J.C., Hance B.K., White J.M. Investigation of rapid-thermal-oxidized porous silicon. Appl. Phys. Lett. 1993, 62:3501-3503.
90. Salonen J., Lehto V.-P., Laine E. Thermal oxidation of free-standing porous silicon films. Appl. Phys. Lett. 1997, 70:637-639.
91. Hurley P.T., Ribbe A.E., Buriak J.M. Nanopatterning of alkynes on hydrogen-terminated silicon surfaces by scanning probe-induced cathodic electrografting. J. Am. Chem. Soc. 2003, 125:11334-11339.
92. Holland J.M., Stewart M.P., Allen M.J., Buriak J.M. Metal mediated reactions on porous silicon surfaces. J. Solid State Chem. 1999, 147:251-258.
93. Buriak J.M. Organometallic chemistry on silicon surfaces: formation of functional monolayers bound through SiC bonds. Chem. Commun. 1999, 1051-1060.
94. Salonen J., Laine E., Niinisto L. Thermal carbonization of porous silicon surface by acetylene. J. Appl. Phys. 2002, 91:456-461.
95. Hilliard L.R., Zhao X., Tan W. Immobilization of oligonucleotides onto silica nanoparticles for DNA hybridization studies. Anal. Chim. Acta 2002, 470:51-56.
96. Qhobosheane M., Santra S., Zhang P., Tan W. Biochemically functionalized silica nanoparticles. Analyst 2001, 126:1274-1278.
97. Schlossbauer A., Kecht J., Bein T. Biotin-avidin as a protease-responsive cap system for controlled guest release from colloidal mesoporous silica. Angew. Chem. Int. Ed. 2009, 48:3092-3095.
98. Sadasivan S., Sukhorukov G.B. Fabrication of hollow multifunctional spheres containing MCM-41 nanoparticles and magnetite nanoparticles using layer-by-layer method. J. Colloid Interface Sci. 2006, 304:437-441.
99. Godin B., Touitou E. Nanoparticles aiming at specific targets-dermal and transdermal delivery. Nanoparticles for Pharmaceutical Applications 2007, American Scientific Publishers, Valencia. A.J. Domb, Y. Tabata, M.N.V. Ravi Kumar, S. Farber (Eds.).
100. Godin B., Gu J., Serda R.E., Liu X., Ferrati S., Chiappini C., Tanaka T., Decuzzi P., Ferrari M. Multistage mesoporous silicon-based nanocarriers: biocompatibility and controlled degradation in physiological fluids. Control. Release Newsl. 2008, 25:9-11.
101. Serda R.E., Mack A., Pulikkathara M., Zaske A.M., Chiappini C., Fakhoury J.R., Webb D., Godin B., Conyers J.L., Liu X.W., Bankson J.A., Ferrari M. Cellular association and assembly of a multistage delivery system. Small 2010, 6:1329-1340.
102. Tasciotti E., Godin B., Martinez J.O., Chiappini C., Bhavane R., Liu X., Ferrari M. Near-infrared imaging method for the in vivo assessment of the biodistribution of nanoporous silicon particles. Mol. Imaging 2011, 10:56-68.
103. Souza G.R., Christianson D.R., Staquicini F.I., Ozawa M.G., Snyder E.Y., Sidman R.L., Miller J.H., Arap W., Pasqualini R. Networks of gold nanoparticles and bacteriophage as biological sensors and cell-targeting agents. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:1215-1220.
104. Srinivasan S., Dressen W.P., Proneth B., Alexander J.F., Hu Y., Liu X., Arap W., Pasqualini R., Ferrari M. Multifunctional nanoassemblies: selective interactions with breast cancer cells. Controlled Release Society Annual Meeting, Maryland 2011.
105. Godin B., Gu J., Serda R.E., Bhavane R., Tasciotti E., Chiappini C., Liu X., Tanaka T., Decuzzi P., Ferrari M. Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation. J. Biomed. Mater. Res. A 2010, 94:1236-1243.
106. Serda R.E., Ferrati S., Godin B., Tasciotti E., Liu X., Ferrari M. Mitotic trafficking of silicon microparticles. Nanoscale 2009, 1:250-259.
107. Serda R.E., Mack A., Pulikkathara M., Zaske A.M., Chiappini C., Fakhoury J., Webb D., Godin B., Conyers J.L., Liu X.W., Bankson J.A., Ferrari M. Cellular association and assembly of a multistage delivery system. Small 2010, 6:1329-1340.
108. Serda R.E., Mack A., van de Ven A.L., Ferrati S., Dunner K., Godin B., Chiappini C., Landry M., Brousseau L., Liu X., et al. Logic-embedded vectors for intracellular partitioning, endosomal escape, and exocytosis of nanoparticles. Small 2010, 6:2691-2700.
109. Yu T., Malugin A., Ghandehari H. Impact of silica nanoparticle design on cellular toxicity and hemolytic activity. ACS Nano 2011, 5:5717-5728.
110. Xie G., Sun J., Zhong G., Shi L., Zhang D. Biodistribution and toxicity of intravenously administered silica nanoparticles in mice. Arch. Toxicol. 2010, 84:183-190.
111. Choi J., Zhang Q., Reipa V., Wang N.S., Stratmeyer M.E., Hitchins V.M., Goering P.L. Comparison of cytotoxic and inflammatory responses of photoluminescent silicon nanoparticles with silicon micron-sized particles in RAW 264.7 macrophages. J. Appl. Toxicol. 2009, 29:52-60.
112. Canham L.T., INSPEC (Information service) Properties of Porous Silicon 1987, INSPEC, London.
113. Napierska D., Thomassen L.C.J., Rabolli V., Lison D., Gonzalez L., Kirsch-Volders M., Martens J.A., Hoet P.H. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small 2009, 5:846-853.
114. Bauer A.T., Strozyk E.A., Gorzelanny C., Westerhausen C., Desch A., Schneider M.F., Schneider S.W. Cytotoxicity of silica nanoparticles through exocytosis of von Willebrand factor and necrotic cell death in primary human endothelial cells. Biomaterials 2011, 32:8385-8393.
115. Zhao Y., Sun X., Zhang G., Trewyn B.G., Slowing I.I., Lin V.S.Y. Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects. ACS Nano 2011, 5:1366-1375.
116. Maurer-Jones M.A., Lin Y.-S., Haynes C.L. Functional assessment of metal oxide nanoparticle toxicity in immune cells. ACS Nano 2010, 4:3363-3373.
117. Godin B., Gu J., Serda R.E., Bhavane R., Tasciotti E., Chiappini C., Liu X., Tanaka T., Decuzzi P., Ferrari M. Tailoring the degradation kinetics of mesoporous silicon structures through PEGylation. J. Biomed. Mater. Res. A 2010, 94A:1236-1243.
118. Bimbo L.M., Mäkilä E., Laaksonen T., Lehto V.-P., Salonen J., Hirvonen J., Santos H.A. Drug permeation across intestinal epithelial cells using porous silicon nanoparticles. Biomaterials 2011, 32:2625-2633.
119. Sohaebuddin S.K., Thevenot P.T., Baker D., Eaton J.W., Tang L. Nanomaterial cytotoxicity is composition, size, and cell type dependent. Part. Fibre Toxicol. 2010, 7:1-17.
120. Waters K.M., Masiello L.M., Zangar R.C., Karin N.J., Quesenberry R.D., Bandyopadhyay S., Teeguarden J.G., Pounds J.G., Thrall B.D. Macrophage responses to silica nanoparticles are highly conserved across particle sizes. Toxicol. Sci. 2009, 107:553-569.
121. Jeong Y.S., Oh W.-K., Kim S., Jang J. Cellular uptake, cytotoxicity, and ROS generation with silica/conducting polymer core/shell nanospheres. Biomaterials 2011, 32:7217-7225.
122. Yuan H., Gao F., Zhang Z., Miao L., Yu R., Zhao H., Lan M. Study on controllable preparation of silica nanoparticles with multi-sizes and their size-dependent cytotoxicity in phaeochromaocytoma cells and human embroynic kidney cells. Water12 2010, 56:632-640.
123. Fisichella M., Dabboue H., Bhattacharyya S., Lelong G., Saboungi M.L., Warmont F., Midoux P., Pichon C., Guerin M., Hevor T., Salvetat J.P. Uptake of functionalized mesoporous silica nanoparticles by human cancer cells. J. Nanosci. Nanotechnol. 2010, 10:2314-2324.
124. Di Pasqua A.J., Sharma K.K., Shi Y.L., Toms B.B., Ouellette W., Dabrowiak J.C., Asefa T. Cytotoxicity of mesoporous silica nanomaterials. J. Inorg. Biochem. 2008, 102:1416-1423.
125. 2 particles in HeLa cells. Arch. Toxicol. 2011, 85:813-826.
126. De Angelis F., Pujia A., Falcone C., Iaccino E., Palmieri C., Liberale C., Mecarini F., Candeloro P., Luberto L., de Laurentiis A., Das G., Scala G., Di Fabrizio E. Water soluble nanoporous nanoparticle for in vivo targeted drug delivery and controlled release in B cells tumor context. Nanoscale 2010, 2.
127. Tao Z., Toms B.B., Goodisman J., Asefa T. Mesoporosity and functional group dependent endocytosis and cytotoxicity of silica nanomaterials. Chem. Res. Toxicol. 2009, 22:1869-1880.
128. Park M.V.D.Z., Annema W., Salvati A., Lesniak A., Elsaesser A., Barnes C., McKerr G., Howard C.V., Lynch I., Dawson K.A., Piersma A.H., Jong W.H.d. In vitro development toxicity test detects inhibition of stem cell differentiation by silica nanoparticles. Toxicol. Appl. Pharmacol. 2009, 240:108-116.
129. Ariano P., Zamburlin P., Gilardino A., Mortera R., Onida B., Tomatis M., Ghiazza M., Fubini B., Lovisolo D. Interaction of spherical silica nanoparticles with neuronal cells: size-dependent toxicity and perturbation of calcium homeostasis. Small 2011, 7:766-774.
130. Drescher D., Orts-Gil G., Laube G., Natte K., Veh R., Österle W., Kneipp J. Toxicity of amorphous silica nanoparticles on eukaryotic cell model is determined by particle agglomeration and serum protein adsorption effects. Anal. Bioanal. Chem. 2011, 400:1367-1373.
131. Tanaka T., Mangala L.S., Vivas-Mejia P.E., Nieves-Alicea R., Mann A.P., Mora E., Han H.D., Shahzad M.M., Liu X., Bhavane R., et al. Sustained small interfering RNA delivery by mesoporous silicon particles. Cancer Res. 2010, 70:3687-3696.
132. Lu X., Tian Y., Zhao Q., Jin T., Xiao S., Fan X. Integrated metabonomics analysis of the size-response relationship of silica nanoparticles-induced toxicity in mice. Nanotechnology 2011, 22:055101.
133. Tanaka T., Godin B., Bhavane R., Nieves-Alicea R., Gu J., Liu X., Chiappini C., Fakhoury J.R., Amra S., Ewing A., Li Q., Fidler I.J., Ferrari M. In vivo evaluation of safety of nanoporous silicon carriers following single and multiple dose intravenous administrations in mice. Int. J. Pharm. 2010, 402:190-197.
134. Decuzzi P., Godin B., Tanaka T., Lee S.Y., Chiappini C., Liu X., Ferrari M. Size and shape effects in the biodistribution of intravascularly injected particles. J. Control. Release 2010, 141:320-327.
135. He Q., Zhang Z., Gao F., Li Y., Shi J. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. Small 2011, 7:271-280.
136. Liu T., Li L., Teng X., Huang X., Liu H., Chen D., Ren J., He J., Tang F. Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice. Biomaterials 2011, 32:1657-1668.
137. Bimbo L.M., Sarparanta M., Santos H.l.A., Airaksinen A.J., Mäkilä E., Laaksonen T., Peltonen L., Lehto V.-P., Hirvonen J., Salonen J. Biocompatibility of thermally hydrocarbonized porous silicon nanoparticles and their biodistribution in rats. ACS Nano 2010, 4:3023-3032.
138. Kumar R., Roy I., Ohulchanskky T.Y., Vathy L.A., Bergey E.J., Sajjad M., Prasad P.N. In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles. ACS Nano 2010, 4:699-708.
139. Cho W.-S., Duffin R., Poland C.A., Howie S.E.M., MacNee W., Bradley M., Megson I.L., Donaldson K. Metal oxide nanoparticles induce unique inflammatory footprints in the lung: important implications for nanoparticle testing. Environ. Health Perspect. 2010, 118.
140. Refuerzo J.S., Godin B., Bishop K., Srinivasan S., Shah S.K., Amra S., Ramin S.M., Ferrari M. Size of the nanovectors determines the transplacental passage in pregnancy: study in rats. Am. J. Obstet. Gynecol. 2011, 204. (546.e545-546.e549).
141. Yamashita K., Yoshioka Y., Higashisaka K., Mimura K., Morishita Y., Nozaki M., Yoshida T., Ogura T., Nabeshi H., Nagano K., Abe Y., Kamada H., Monobe Y., Imazawa T., Aoshima H., Shishido K., Kawai Y., Mayumi T., Tsunoda S.-i., Itoh N., Yoshikawa T., Yanagihara I., Saito S., Tsutsumi Y. Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat. Nanotechnol. 2011, 6:321-328.
142. Chen Z., Meng H., Xing G.M., Yuan H., Zhao F., Liu R., Chang X.L., Gao X.Y., Wang T.C., Jia G., Ye C., Chai Z.F., Zhao Y.L. Age-related differences in pulmonary and cardiovascular responses to SiO(2) nanoparticle inhalation: nanotoxicity has susceptible population. Environ. Sci. Technol. 2008, 42:8985-8992.
143. Ding M., Chen F., Shi X., Yucesoy B., Mossman B., Vallyathan V. Diseases caused by silica: mechanisms of injury and disease development. Int. Immunopharmacol. 2002, 2:173-182.
144. Hnizdo E., Vallyathan V. Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence. Occup. Environ. Med. 2003, 60:237-243.
145. Merget R., Bauer T., Kupper H.U., Philippou S., Bauer H.D., Breitstadt R., Bruening T. Health hazards due to the inhalation of amorphous silica. Arch. Toxicol. 2002, 75:625-634.
146. Thibodeau M.S., Giardina C., Knecht D.A., Helble J., Hubbard A.K. Silica-induced apoptosis in mouse alveolar macrophages is initiated by lysosomal enzyme activity. Toxicol. Sci. 2004, 80:34-48.
147. Ale-Agha N., Albrecht C., Klotz L.-O. Loss of gap junctional intercellular communication in rat lung epithelial cells exposed to carbon or silica-based nanoparticles. Biological Chemistry 2010, 1333.
148. Akhtar M.J., Ahamed M., Kumar S., Siddiqui H., Patil G., Ashquin M., Ahmad I. Nanotoxicity of pure silica mediated through oxidant generation rather than glutathione depletion in human lung epithelial cells. Toxicology 2010, 276:95-102.
149. Lin W., Huang Y.-w., Zhou X.-D., Ma Y. In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol. Appl. Pharmacol. 2006, 217:252-259.
150. Lison D., Thomassen L.C.J., Rabolli V., Gonzalez L., Napierska D., Seo J.W., Kirsch-Volders M., Hoet P., Kirschhock C.E.A., Martens J.A. Nominal and effective dosimetry of silica nanoparticles in cytotoxicity assays. Toxicol. Sci. 2008, 104:155-162.
151. Sayes C.M., Reed K.L., Warheit D.B. Assessing toxicity of fine and nanoparticles: comparing in vitro measurements to in vivo pulmonary toxicity profiles. Toxicol. Sci. 2007, 97:163-180.
152. Barillet S., Jugan M.-L., Laye M., Leconte Y., Herlin-Boime N., Reynaud C., Carriere M. In vitro evaluation of SiC nanoparticle impact on A549 pulmonary cells: cyto-, genotoxicity and oxidative stress. Toxicol. Lett. 2010, 198:324-330.
153. Shi Y., Yadav S., Wang F., Wang H. Endotoxin promotes adverse effects of amorphous silica nanoparticles on lung epithelial cells in vitro. J. Toxicol. Environ. Health A 2010, 73:748-756.
154. Al-Salam S., Balhaj G., Al-Hammadi S., Sudhadevi M., Tariq S., Biradar A.V., Asefa T., Souid A.K. In vitro study and biocompatibility of calcined mesoporous silica microparticles in mouse lung. Toxicol. Sci. 2011, 122:86-99.
155. Sayes C.M., Reed K.L., Glover K.P., Swain K.A., Ostraat M.L., Donner E.M., Warheit D.B. Changing the dose metric for inhalation toxicity studies: short-term study in rats with engineered aerosolized amorphous silica nanoparticles. Inhal. Toxicol. 2010, 22:348-354.
156. Warheit D.B., Webb T.R., Colvin V.L., Reed K.L., Sayes C.R. Pulmonary bioassay studies with nanoscale and fine-quartz particles in rats: toxicity is not dependent upon particle size but on surface characteristics. Toxicol. Sci. 2007, 95:270-280.
157. Kaewamatawong T., Shimada A., Okajima M., Inoue H., Morita T., Inoue K., Takano H. Acute and subacute pulmonary toxicity of low dose of ultrafine colloidal silica particles in mice after intratracheal instillation. Toxicol. Pathol. 2006, 34:958-965.
158. Song Y., Li X., Wang L., Rojanasakul Y., Castranova V., Li H., Ma J. Nanomaterials in humans. Toxicol. Pathol. 2011, 39:841-849.
159. Eskandar N.G., Simovic S., Prestidge C.A. Nanoparticle coated emulsions as novel dermal delivery vehicles. Curr. Drug Deliv. 2009, 6:367-373.
160. Touitou E. Drug delivery across the skin. Expert. Opin. Biol. Ther. 2002, 2:723-733.
161. Cevc G., Vierl U. Nanotechnology and the transdermal route: a state of the art review and critical appraisal. J. Control. Release 2010, 141:277-299.
162. Honeywell-Nguyen P.L., de Graaff A.M., Groenink H.W., Bouwstra J.A. The in vivo and in vitro interactions of elastic and rigid vesicles with human skin. Biochim. Biophys. Acta 2002, 1573:130-140.
163. Skin Barrier 2006, Taylor & Francis Group, New York. P.M. Elias, K.R. Ferngold (Eds.).
164. Park Y.H., Kim J.N., Jeong S.H., Choi J.E., Lee S.H., Choi B.H., Lee J.P., Sohn K.H., Park K.L., Kim M.K., Son S.W. Assessment of dermal toxicity of nanosilica using cultured keratinocytes, a human skin equivalent model and an in vivo model. Toxicology 2010, 267:178-181.
165. Zhang Y., Hu L., Yu D., Gao C. Influence of silica particle internalization on adhesion and migration of human dermal fibroblasts. Biomaterials 2010, 31:8465-8474.
166. Nabeshi H., Yoshikawa T., Matsuyama K., Nakazato Y., Arimori A., Isobe M., Tochigi S., Kondoh S., Hirai T., Akase T., Yamashita T., Yamashita K., Yoshida T., Nagano K., Abe Y., Yoshioka Y., Kamada H., Imazawa T., Itoh N., Tsunoda S., Tsutsumi Y. Size-dependent cytotoxic effects of amorphous silica nanoparticles on Langerhans cells. Pharmazie 2010, 65:199-201.
167. Nabeshi H., Yoshikawa T., Matsuyama K., Nakazato Y., Tochigi S., Kondoh S., Hirai T., Akase T., Nagano K., Abe Y., Yoshioka Y., Kamada H., Itoh N., Tsunoda S.-i., Tsutsumi Y. Amorphous nanosilica induce endocytosis-dependent ROS generation and DNA damage in human keratinocytes. Part. Fibre Toxicol. 2011, 8:1.
168. Boonen J., Baert B., Lambert J., De Spiegeleer B. Skin penetration of silica microparticles. Pharmazie 2011, 66:463-464.
169. Graf C., Meinke M., Gao Q., Hadam S., Raabe J., Sterry W., Blume-Peytavi U., Lademann J., Ruhl E., Vogt A. Qualitative detection of single submicron and nanoparticles in human skin by scanning transmission x-ray microscopy. J. Biomed. Opt. 2009, 14:021015.
170. Ghouchi Eskandar N., Simovic S., Prestidge C.A. Nanoparticle coated submicron emulsions: sustained in-vitro release and improved dermal delivery of all-trans-retinol. Pharm. Res. 2009, 26:1764-1775.
171. Kosmulski M. Compilation of PZC and IEP of sparingly soluble metal oxides and hydroxides from literature. Adv. Colloid Interface Sci. 2009, 152:14-25.
172. Popov A.P., Priezzhev A.V., Lademann J., Myllyla R. Biophysical mechanisms of modification of skin optical properties in the UV wavelength range with nanoparticles. J. Appl. Phys. 2009, 105:102035.
173. Ramesan R.M., Sharma C.P. Challenges and advances in nanoparticle-based oral insulin delivery. Expert Rev. Med. Devices 2009, 6.6:665.
174. Cheng S.-H., Liao W.-N., Chen L.-M., Lee C.-H. pH-controllable release using functionalized mesoporous silica nanoparticles as an oral drug delivery system. J. Mater. Chem. 2011, 21.
175. Foraker A.B., Walczak R.J., Cohen M.H., Boiarski T.A., Grove C.F., Swaan P.W. Microfabricated porous silicon particles enhance paracellular delivery of insulin across intestinal Caco-2 cell monolayers. Pharm. Res. 2003, 20:110-116.
176. Tan A., Simovic S., Davey A.K., Rades T., Boyd B.J., Prestidge C.A. Silica nanoparticles to control the lipase-mediated digestion of lipid-based oral delivery systems. Mol. Pharm. 2010, 7:522-532.
177. Chu Z., Huang Y., Tao Q., Li Q. Cellular uptake, evolution, and excretion of silica nanoparticles in human cells. Nanoscale 2011, 3:3291-3299.
178. Nishimori H., Kondoh M., Isoda K., Tsunoda S.-i., Tsutsumi Y., Yagi K. Silica nanoparticles as hepatotoxicants. Eur. J. Pharm. Biopharm. 2009, 72:496-501.
179. Wang F., Hui H., Barnes T.J., Barnett C., Prestidge C.A. Oxidized mesoporous silicon microparticles for improved oral delivery of poorly soluble drugs. Mol. Pharm. 2009, 7:227-236.
180. Mellaerts R., Mols R., Jammaer J.A., Aerts C.A., Annaert P., Van Humbeeck J., Van den Mooter G., Augustijns P., Martens J.A. Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silica. Eur. J. Pharm. Biopharm. 2008, 69:223-230.
181. Van Speybroeck M., Mols R., Mellaerts R., Thi T.D., Martens J.A., Van Humbeeck J., Annaert P., Van den Mooter G., Augustijns P. Combined use of ordered mesoporous silica and precipitation inhibitors for improved oral absorption of the poorly soluble weak base itraconazole. Eur. J. Pharm. Biopharm. 2010, 75:354-365.
182. Salonen J., Laitinen L., Kaukonen A.M., Tuura J., Björkqvist M., Heikkilä T., Vähä-Heikkilä K., Hirvonen J., Lehto V.P. Mesoporous silicon microparticles for oral drug delivery: loading and release of five model drugs. J. Control. Release 2005, 108:362-374.
183. Heikkila T., Salonen J., Tuura J., Kumar N., Salmi T., Murzin D.Y., Hamdy M.S., Mul G., Laitinen L., Kaukonen A.M., Hirvonen J., Lehto V.P. Evaluation of mesoporous TCPSi, MCM-41, SBA-15, and TUD-1 materials as API carriers for oral drug delivery. Drug Deliv. 2007, 14:337-347.
184. Zhang Y., Zhi Z., Jiang T., Zhang J., Wang Z., Wang S. Spherical mesoporous silica nanoparticles for loading and release of the poorly water-soluble drug telmisartan. J. Control. Release 2010, 145:257-263.
185. Lee C.-H., Lo L.-W., Mou C.-Y., Yang C.-S. Synthesis and characterization of positive-charge functionalized mesoporous silica nanoparticles for oral drug delivery of an anti-inflammatory drug. Adv. Funct. Mater. 2008, 18:3283-3292.
186. Albrecht D.S., Lee J.T., Molby N., Rhodes S.D., Dam H.M., Siegel J.L., Porter L.A. Functionalized porous silicon in a simulated gastrointestinal tract: modeling the biocompatibility of a monolayer protected nanostructured material. Mater. Res. Soc. Symp. Proc. 2008, 1063.
187. Tan A., Simovic S., Davey A.K., Rades T., Prestidge C.A. Silica-lipid hybrid (SLH) microcapsules: a novel oral delivery system for poorly soluble drugs. J. Control. Release 2009, 134:62-70.
188. Uskoković V., Lee P.P., Walsh L.A., Fischer K.E., Desai T.A. PEGylated silicon nanowire coated silica microparticles for drug delivery across intestinal epithelium. Biomaterials 2012, 33:1663-1672.
189. Laaksonen T., Santos H., Vihola H., Salonen J., Riikonen J., Heikkila T., Peltonen L., Kumar N., Murzin D.Y., Lehto V.P., Hirvonen J. Failure of MTT as a toxicity testing agent for mesoporous silicon microparticles. Chem. Res. Toxicol. 2007, 20:1913-1918.
190. Jin Y., Kannan S., Wu M., Zhao J.X. Toxicity of luminescent silica nanoparticles to living cells. Chem. Res. Toxicol. 2007, 20:1126-1133.
191. Karlsson H.L. The comet assay in nanotoxicology research. Anal. Bioanal. Chem. 2010, 398:651-666.
192. Schins R.P. Mechanisms of genotoxicity of particles and fibers. Inhal. Toxicol. 2002, 14:57-78.
193. 2 nanoparticles. Exp. Cell Res. 2005, 305:51-62.
194. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 1997, 68:1-506. World Health Organization International Agency for Research on Cancer.
195. Borm P.J.A., Tran L., Donaldson K. The carcinogenic action of crystalline silica: a review of the evidence supporting secondary inflammation-driven genotoxicity as a principal mechanism. Crit. Rev. Toxicol. 2011, 41:756-770.
196. Zhang Z., Shen H.-M., Zhang Q.-F., Ong C.-N. Involvement of oxidative stress in crystalline silica-induced cytotoxicity and genotoxicity in rat alveolar macrophages. Environ. Res. 2000, 82:245-253.
197. 2 particulate in cultured human lymphoblastoid cells. Environ. Mol. Mutagen. 2007, 48:151-157.
198. Gerloff K., Albrecht C., Boots A.W., Förster I., Schins R.P.F. Cytotoxicity and oxidative DNA damage by nanoparticles in human intestinal Caco-2 cells. Nanotoxicology 2009, 3:355-364.
199. Choi H.-S., Kim Y.-J., Song M., Song M.-K., Ryu J.-C. Genotoxicity of nano-silica in mammalian cell lines. Toxicol. Environ. Heal. Sci. 2011, 3:7-13.
200. 2 nanoparticles induce global genomic hypomethylation in HaCaT cells. Biochem. Biophys. Res. Commun. 2010, 397:397-400.
201. Huang X., Zhuang J., Teng X., Li L., Chen D., Yan X., Tang F. The promotion of human malignant melanoma growth by mesoporous silica nanoparticles through decreased reactive oxygen species. Biomaterials 2010, 31:6142-6153.
202. Barnes C.A., Elsaesser A., Arkusz J., Smok A., Palus J., Leśniak A., Salvati A., Hanrahan J.P., Jong W.H.d., Dziubałtowska E.b., Stȩpnik M., Rydzyński K., McKerr G., Lynch I., Dawson K.A., Howard C.V. Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity. Nano Lett. 2008, 8:3069-3074.
203. Park M.V., Verharen H.W., Zwart E., Hernandez L.G., van Benthem J., Elsaesser A., Barnes C., McKerr G., Howard C.V., Salvati A., Lynch I., Dawson K.A., de Jong W.H. Genotoxicity evaluation of amorphous silica nanoparticles of different sizes using the micronucleus and the plasmid lacZ gene mutation assay. Nanotoxicology 2011, 5:168-181.
204. Aillon K.L., Xie Y., El-Gendy N., Berkland C.J., Forrest M.L. Effects of nanomaterial physicochemical properties on in vivo toxicity. Adv. Drug Deliv. Rev. 2009, 61:457-466.
205. Yang H., Liu C., Yang D., Zhang H., Xi Z. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J. Appl. Toxicol. 2009, 29:69-78.
206. Durnev A.D., Solomina A.S., Daugel-Dauge N.O., Zhanataev A.K., Shreder E.D., Nemova E.P., Shreder O.V., Veligura V.A., Osminkina L.A., Timoshenko V.Y., Seredenin S.B. Evaluation of genotoxicity and reproductive toxicity of silicon nanocrystals. Bull. Exp. Biol. Med. 2010, 149:445-449.
207. Kneuer C., Sameti M., Bakowsky U., Schiestel T., Schirra H., Schmidt H., Lehr C.M. A nonviral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells in vitro. Bioconjug. Chem. 2000, 11:926-932.
208. Ravi Kumar M.N.V., Sameti M., Mohapatra S.S., Kong X., Lockey R.F., Bakowsky U., Lindenblatt G., Schmidt H., Lehr C.M. Cationic silica nanoparticles as gene carriers: synthesis, characterization and transfection efficiency in vitro and in vivo. J. Nanosci. Nanotechnol. 2004, 4:876-881.
209. Xue Z.-G., Zheng D., Ruan J.-M., Pan Q., Zhao D.-C., Liu X.-P., Chen Y.-X., Xia J.-H., Xia K. Silica nanoparticles modified as carriers for gene transfection. Yi Chuan Xue Bao 2003, 30:606-610.
210. Zhang H.Y., Lee M.Y., Hogg M.G., Dordick J.S., Sharfstein S.T. Gene delivery in three-dimensional cell cultures by superparamagnetic nanoparticles. ACS Nano 2010, 4:4733-4743.
211. Ciofani G., Ricotti L., Menciassi A., Mattoli V. Preparation, characterization and in vitro testing of poly(lactic-co-glycolic) acid/barium titanate nanoparticle composites for enhanced cellular proliferation. Biomed. Microdevices 2011, 13:255-266.
212. Child H.W., del Pino P.A., De la Fuente J.M., Hursthouse A.S., Stirling D., Mullen M., McPhee G.M., Nixon C., Jayawarna V., Berry C.C. Working together: the combined application of a magnetic field and penetratin for the delivery of magnetic nanoparticles to cells in 3D. ACS Nano 2011, 5:7910-7919.